We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OPTN market cap is 65.59M. The company's latest EPS is USD -0.2353 and P/E is -1.83.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 19.45M | 19.82M | 19.87M | 14.88M | 20.49M |
Operating Income | -4.17M | -1.69M | -2.51M | -8.08M | -6.55M |
Net Income | 2.62M | -9.29M | -9.97M | -14.07M | -7.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 34.63M | 49.12M | 74.65M | 76.28M | 70.99M |
Operating Income | -96M | -87.22M | -66.45M | -55.9M | -22.75M |
Net Income | -110.45M | -99.79M | -82.3M | -74.83M | -35.48M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 106.07M | 101.41M | 107.73M | 83.71M | 131.87M |
Total Liabilities | 175.73M | 179.02M | 194.34M | 182.92M | 174.73M |
Total Equity | -69.66M | -77.62M | -86.61M | -99.22M | -42.85M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 172.65M | 188.81M | 166.07M | 144.22M | 107.73M |
Total Liabilities | 111.07M | 182.03M | 187.84M | 200.85M | 194.34M |
Total Equity | 61.58M | 6.79M | -21.77M | -56.62M | -86.61M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.02M | -27.44M | -20.53M | -22.03M | -37.72M |
Investing | -79k | -255k | -328k | -22k | -51k |
Financing | 162k | 296k | 300k | 7k | 55.44M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -90.82M | -86.21M | -76.94M | -67.65M | -20.53M |
Investing | -557k | -546k | -62k | -63k | -328k |
Financing | 37.53M | 83.81M | 43.32M | 51.44M | 300k |
Market Cap | 65.59M |
Price to Earnings Ratio | -1.83 |
Price to Sales Ratio | 0.91 |
Price to Cash Ratio | 0.88 |
Price to Book Ratio | -0.75 |
Dividend Yield | - |
Shares Outstanding | 150.78M |
Average Volume (1 week) | 1.96M |
Average Volume (1 Month) | 657.91k |
52 Week Change | -64.92% |
52 Week High | 2.10 |
52 Week Low | 0.413 |
Spread (Intraday) | 0.09 (17.49%) |
Company Name | OptiNose Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.optinose.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions